Rae Legaualt's Colleagues at Antibe Therapeutics Inc.
Rae Legaualt's Contact Details
416-849-8115
Canada
Antibe Therapeutics Inc.
Rae Legaualt's Company Details
Antibe Therapeutics is a publicly traded biotechnology company pursuing a breakthrough advance in the treatment of inflammation. Our drug pipeline addresses major markets in non-addictive management of chronic and post-surgical pain. Antibe's lead drug, now in late Phase 2 trials, is demonstrating unprecedented safety in the treatment of chronic pain, a condition that affects more than 50 million Americans alone. Our second pipeline drug is intended to replace a range of opioids, addressing a vast and pressing public health concern. Our third drug is a safer daily aspirin -- delivering anti-stroke and anti-cancer benefits without damage to the digestive tract.